NYSE:CLB
Core Laboratories Inc.
Core Laboratories Inc.'s revenue grew 0.5% in fiscal 2025 to $526.5M while operating margin fell to 10.7%. Free cash flow was $25.8M, 4.9% of revenue, and the diluted share count fell 1.4%.Summary generated from Core Laboratories Inc.'s SEC filings. Latest annual report filed Mar 23, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$526.5M
Revenue growth+0.5%
Revenue, 5-yr CAGRn/a
Gross margin20.7%
Operating margin10.7%
Net margin5.6%
ROIC10.5%
Return on equity11.6%
Debt / equity0.42
Free cash flow$25.8M
FCF margin4.9%
Share count change−1.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 470 | 490 | 510 | 524 | 527 |
| Operating income | 45 | 42 | 55 | 59 | 56 |
| Net income | 20 | 19 | 37 | 31 | 30 |
| Free cash flow | 23 | 15 | 14 | 45 | 26 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Oct 5, 2026 - 8-KDirector or officer change
Aug 25, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 29, 2026 - 8-KResults of a shareholder vote
May 13, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 1, 2026 - 8-KResults of operations and financial condition
Apr 29, 2026